Additionally, blocking FGF2 signaling in breast cancer cells in the presence of BM, tnLCM or tbLCM had minimal influence on inhibiting acquisition of stem-like ALDHhiCD44+ phenotype. This evidence concerns the gene FGF2 and breast cancer.